Literature DB >> 8275435

Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues.

D Y Noh1, Y H Lee, S S Kim, Y I Kim, S H Ryu, P G Suh, J G Park.   

Abstract

BACKGROUND: Phospholipase C isozymes (PLC) play a role in ligand-mediated signal transduction for cellular activity, such as proliferation and differentiation. However, the biologic significance of their molecules in carcinogenesis or tumor progression is yet to be determined.
METHODS: Using PLC isozyme-specific antibodies, the relative content of PLC in human colorectal carcinomas and in normal colonic mucosa was examined.
RESULTS: Immunoreactive analysis revealed considerably higher levels of PLC-gamma 1 protein in 15 of 17 colorectal carcinomas and little difference in PLC-beta 1 or PLC-gamma 1 content compared with normal colorectal tissues. By radioimmunoassay and Western blotting, PLC-gamma 1 showed three-fold to fourfold more expression in carcinomas than that in normal tissues.
CONCLUSION: Although factors that might influence the level of PLC-gamma 1 expression in colorectal carcinomas still remain obscure, the fact that most colorectal carcinomas display elevated levels of PLC-gamma 1 expression implies that PLC-gamma 1 may play an important role in proliferation of colorectal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275435     DOI: 10.1002/1097-0142(19940101)73:1<36::aid-cncr2820730108>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Raf-1 kinase, epidermal growth factor receptors, and mutant Ras proteins in colonic carcinomas.

Authors:  S Eggstein; G Manthey; T Hirsch; F Baas; B U Specht; E H Farthmann
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.

Authors:  Mikel Garcia-Marcos; Barbara H Jung; Jason Ear; Betty Cabrera; John M Carethers; Pradipta Ghosh
Journal:  FASEB J       Date:  2010-10-25       Impact factor: 5.191

Review 3.  Phospholipase Signaling in Breast Cancer.

Authors:  Yu Jin Lee; Kyeong Jin Shin; Hyun-Jun Jang; Dong-Young Noh; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Genetic mapping of the human and mouse phospholipase C genes.

Authors:  M S Lyu; D J Park; S G Rhee; C A Kozak
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

5.  Critical role for the catalytic activity of phospholipase C-gamma1 in epidermal growth factor-induced cell migration.

Authors:  Zhongjian Xie; Jian Peng; Sally D Pennypacker; Ying Chen
Journal:  Biochem Biophys Res Commun       Date:  2010-07-30       Impact factor: 3.575

6.  Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells.

Authors:  Jin Ku Kang; Chang-Hyun Chang; Hyo Jung Nam; Sung-Kuk Kim; Keun Jae Ahn; Heon Seok; Sang Joon Park; Yoon Joong Kang; Young Suk Jo; Minho Shong; Ho Kim
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

7.  Phospholipase C-gamma1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis.

Authors:  Zhongjian Xie; Ying Chen; Er-Yuan Liao; Yi Jiang; Fu-You Liu; Sally D Pennypacker
Journal:  Biochem Biophys Res Commun       Date:  2010-05-26       Impact factor: 3.575

Review 8.  Phosphoinositide signalling in cancer: beyond PI3K and PTEN.

Authors:  Tom D Bunney; Matilda Katan
Journal:  Nat Rev Cancer       Date:  2010-05       Impact factor: 60.716

Review 9.  Phospholipase signalling networks in cancer.

Authors:  Jong Bae Park; Chang Sup Lee; Jin-Hyeok Jang; Jaewang Ghim; Youn-Jae Kim; Sungyoung You; Daehee Hwang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

10.  UCP2 upregulation promotes PLCγ-1 signaling during skin cell transformation.

Authors:  Annapoorna Sreedhar; Julia Lefort; Petra Petruska; Xin Gu; Runhua Shi; Sumitra Miriyala; Manikandan Panchatcharam; Yunfeng Zhao
Journal:  Mol Carcinog       Date:  2017-06-30       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.